MHRA set to reclassify glucosamine supplements
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
High-strength glucosamine food supplements sold in the UK will now be classified as medicines and require a marketing authorisation after the country’s Medicines and Healthcare products Regulatory Agency (MHRA) introduced tighter regulations for such products.
You may also be interested in...
France Warns Diabetics And Others Against Using Joint Health Supplements
Diabetics, pregnant women, children, and those with certain food allergies in France should stop taking joint health supplements containing glucosamine and/or chondroitin sulfate due to a risk of adverse events, says national food regulator ANSES. Local supplements industry association Synadiet has insisted the products are safe and cases of adverse reactions rare.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.